IQVIA will be attending the World Vaccine Congress Washington April 22 - 24 in Washington DC. Our team of infectious diseases and vaccines experts will be there to discuss how to intelligently connect data, technology, and analytics to optimize your vaccine trials. Our experience spans Influenza, RSV, Hepatitis B, Tuberculosis, HIV and more.
Visit us at booth # 201 to learn more about how we can help you bring treatments to patients, faster.
Access new resources for advanced therapy development, from candidate identification through market authorization.
Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
.svg){kind=icon}
